Bronchoalveolar Lavages for Cytologic Assessment in Intensive Care Unit Patients
NCT ID: NCT03098888
Last Updated: 2019-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
483 participants
OBSERVATIONAL
2017-04-03
2019-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of this multi center, prospective, observational study is to describe the frequency of use of bronchoalveolar lavages for cytological assessement in critically ill patients, identify their indications, assess their contribution to diagnosis and therapeutic decisions, and estimate the frequency of induced respiratory events.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Microbiota Analysis in Critically Ill Patients Admitted to the Intensive Care Unit.
NCT04271345
A Longitudinal Investigation of Energy Expenditure and Substrate Utilization in Critically Ill Patients
NCT05124860
Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
NCT00745888
Lung Ultrasound Guided Protocol for Fluid Management for the Critically Ill Patient: a Randomized Study
NCT03393065
Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System
NCT04008225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* assess the frequency of poor quality bronchoalveolar lavages (as defined by either more than 5% bronchial epithelial cell count to less than 50,000 alveolar cells per mL)
* assess the contribution of a given bronchoalveolar lavage to the diagnostic work up
* assess the contribution of a given bronchoalveolar lavage results to therapeutic decision
* assess the induced short term respiratory side effects
* identify risk factors for poor respiratory tolerance
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bronchoalveolar lavage
bronchoalveolar lavages performed for cytological assessment in critically ill patients with lung diseases, intubated or not
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient's or family consent
Exclusion Criteria
* patient already included at previous bronchoalveolar lavage of during previous hospitalization
* absence of social security number
* age \< 18yr
* pregnant woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional d'Orléans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Toufik KAMEL, MD
Role: PRINCIPAL_INVESTIGATOR
CHR Orléans
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'ANGERS
Angers, , France
CH d'ANGOULEME
Angoulême, , France
CH Victor DUPOUY
Argenteuil, , France
CHU de DIJON
Dijon, , France
Hôpital RAYMOND POINCARE
Garches, , France
CHD de VENDEE
La Roche-sur-Yon, , France
CH de LA ROCHELLE
La Rochelle, , France
Hopital de La Timone
Marseille, , France
Hôpital Nord de Marseille
Marseille, , France
CH de MONTAUBAN
Montauban, , France
CHRU de NANTES
Nantes, , France
CHR d'ORLEANS
Orléans, , France
CHRU de POITIERS
Poitiers, , France
CHU de STRASBOURG
Strasbourg, , France
CHU de STRASBOURG NHC
Strasbourg, , France
CHRU de TOURS
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N° IDRCB 2017-A00306-47
Identifier Type: OTHER
Identifier Source: secondary_id
CHRO cat III 2017-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.